People
Filter News
Found 52,066 articles
-
CEO Emma Walmsley’s vision includes a projected $46 billion in annual sales from the stand-alone pharma company by 2031 and more than 10% operating profit over the next five years.
-
Veralox Therapeutics Appoints Michael Hanna As Chief Medical Officer
6/23/2021
Veralox Therapeutics today announced the appointment of Michael S. Hanna , MD, FACC, as chief medical officer.
-
Caryn Peterson Joins Aspen Neuroscience Board of Directors
6/23/2021
Aspen Neuroscience, Inc. announced today that Caryn Peterson , executive vice president of Regulatory Affairs for Gossamer Bio, has joined the Aspen Board of Directors.
-
Valneva Announces Successful Outcome of its AGM
6/23/2021
Valneva S E announced today that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting (AGM) held as a closed session at its registered office on June 23, 2021.
-
Milestone Scientific Expands Medical Sales Team to Capitalize on Growing Interest in CompuFlo Including Appointment of Senior Industry Sales Executive Chet Trechock as VP of Sales for Medical
6/23/2021
Milestone Scientific Inc. today announced that it has expanded its medical sales team including the appointment of Chet Trechock as VP of Sales Medical.
-
Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee
6/23/2021
Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), announced the appointment of Sonja Nelson, CPA to the Company’s Board of Directors and as Chair of the Audit Committee.
-
Immusoft Announces Formation of Scientific Advisory Board
6/23/2021
Immusoft, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced today the formation of its Scientific Advisory Board (SAB) composed of world-renowned experts to provide external scientific review and high-level counsel on the Company’s research and development programs.
-
Evogene Announces Ms. Sarit Firon to become Evogene's Chairperson of the Board
6/23/2021
Evogene Ltd. announced today that its Board of Directors has resolved to appoint Ms. Sarit Firon to serve as Chairperson of the Board
-
Omega Therapeutics Expands Board of Directors with Appointment of Luke Beshar
6/23/2021
Omega Therapeutics, Inc. today announced the appointment of Luke Beshar to its Board of Directors.
-
Greg Sukay Joins Arcutis as Vice President of Manufacturing and Process Technologies
6/23/2021
Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, announced that Greg Sukay has joined the company as Vice President, Manufacturing and Process Technologies.
-
CureVac Provides Supervisory Board Update
6/23/2021
CureVac N.V., a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, announced that Dr. Ingmar Hoerr, former Founding-CEO and former member of the Supervisory Board of CureVac, has withdrawn his candidacy for nomination to the Supervisory Board.
-
Edesa Biotech Team Expands Leadership Team with Key Manufacturing Appointment
6/23/2021
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced the appointment of a key member to its management team to support the company's expanding manufacturing activities.
-
Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Financial Officer
6/23/2021
Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced the appointment of Celia Economides as executive vice president and chief financial officer.
-
Theratechnologies Appoints New Board Member
6/23/2021
Theratechnologies Inc. today announced the appointment of Mr. Frank Holler as a new independent member to its Board of Directors.
-
Outset Medical Welcomes Jean-Olivier Racine as Chief Technology Officer
6/23/2021
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer
-
Eric Giza, MD, FACS Joins Alafair Biosciences Scientific & Clinical Advisory Board
6/23/2021
Medical device innovator Alafair Biosciences announces the appointment of Eric Giza, MD, FAAOS to its Scientific & Clinical Advisory Board
-
Amunix Appoints Industry Veteran, Frank Watanabe, to its Board of Directors
6/23/2021
Amunix Pharmaceuticals, Inc. announced that it has expanded its board of directors with the appointment of Frank Watanabe, CEO of Arcutis and a biopharmaceutical executive with extensive leadership, strategy, operations and financing experience.
-
Dr. Peter Bach Joins Delfi Diagnostics as Chief Medical Officer
6/23/2021
Delfi Diagnostics, a developer of next-generation high performance, affordable liquid biopsy tests for early cancer detection, announced today that Peter B. Bach, MD, a lung cancer screening pioneer and health economics expert, has joined as Chief Medical Officer.
-
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
6/23/2021
Draupnir Bio, a biotechnology company developing small molecule modulators of PCSK9 to transform the treatment of heart disease, announces the appointment of Andrew Hotchkiss as Chief Executive Officer.
-
KVK is excited to announce the appointment of Rahul Sareen as Corporate Head of Quality
6/23/2021
KVK-Tech, Inc. and its affiliate Penn Life Sciences, Inc. have announced that they have appointed Rahul Sareen as Corporate Head of Quality.